Therapeutic effects of XI Enkai on mild to moderate vascular dementia and observation of SPECT

Wen-shi WEI,Jie CHANG,Li-juan XU,Xin-yi BAO,Chuan-fu WANG
DOI: https://doi.org/10.3969/j.issn.1008-8296.2008.03.010
2008-01-01
Abstract:Objective To observe therapeutic effects of Xi Enkai on mild to moderate vascular dementia and blood reservation change by SPECT.Methods Mild to moderate VaD patients were randomized into the control group (n=36) receiving aspirin treatment,and the study group (n=32) receiving Xi Enkai.The therapeutic effects were evaluated by MMSE,ADL and ADAS-cog,and cerebral blood reservation change was assessed by SPECT.Results ADAS-cog before treatment was 36.4±5.8 for the study group,and 35.7±5.2 for the control group (P>0.05) versus 33.1±4.2 and 29.9±3.8 three months after treatment (P<0.05).MMSE before treatment was 16.7±3.5 for the study group and 16.3±3.7 for the control group (P>0.05) versus 17.4±4.6 and 15.5±3.3 three months after treatment (P<0.05).ADL before treatments was 45.7±7.5 for the study group and 45.0±6.9 for the control group (P>0.05) versus 43.1±4.6 and 45.8±7.3 three months after treatment (P<0.05).The results of SPECT showed that Xi Enkai improved lower perfusion status in type A patients,improved lower metabolic status in type B patients,and improved insidious ischemic status in type C patients. Conclusion Xi Enkai can improve cognitive function of mild to moderate VaD patients,presumably through the mechanism of enhancing cerebral blood reservation.
What problem does this paper attempt to address?